Search Results - "Modern rheumatology"

The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD by Umehara, Hisanori, Okazaki, Kazuichi, Kawa, Shigeyuki, Takahashi, Hiroki, Goto, Hiroshi, Matsui, Shoko, Ishizaka, Nobukazu, Akamizu, Takashi, Sato, Yasuharu, Kawano, Mitsuhiro

“…IgG4-related disease (IgG4-RD) is a fascinating clinical entity first reported in this century in Japan, and includes a wide variety of diseases, such as…”
Get full text

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients by Qin, Baodong, Ma, Ning, Tang, Qingqin, Wei, Tingting, Yang, Min, Fu, Haitao, Hu, Zhide, Liang, Yan, Yang, Zaixing, Zhong, Renqian

“…Objective: Although there have been extensive investigations on neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and mean platelet…”
Get full text

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 by Umehara, Hisanori, Okazaki, Kazuichi, Masaki, Yasufumi, Kawano, Mitsuhiro, Yamamoto, Motohisa, Saeki, Takako, Matsui, Shoko, Yoshino, Tadashi, Nakamura, Shigeo, Kawa, Shigeyuki, Hamano, Hideaki, Kamisawa, Terumi, Shimosegawa, Toru, Shimatsu, Akira, Nakamura, Seiji, Ito, Tetsuhide, Notohara, Kenji, Sumida, Takayuki, Tanaka, Yoshiya, Mimori, Tsuneyo, Chiba, Tsutomu, Mishima, Michiaki, Hibi, Toshifumi, Tsubouchi, Hirohito, Inui, Kazuo, Ohara, Hirotaka

“…Background IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue…”
Get full text

IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review by Ogata, Atsushi, Kato, Yasuhiro, Higa, Shinji, Yoshizaki, Kazuyuki

“…Tocilizumab (TCZ) is an interleukin-6 (IL-6) inhibitor used for the treatment of rheumatoid arthritis (RA). It was developed in 2008, and its effectiveness is…”
Get full text

Current approach to the diagnosis of IgG4-related disease - Combination of comprehensive diagnostic and organ-specific criteria by Umehara, Hisanori, Okazaki, Kazuichi, Nakamura, Takuji, Satoh-Nakamura, Tomomi, Nakajima, Akio, Kawano, Mitsuhiro, Mimori, Tsuneyo, Chiba, Tsutomu

“…IgG4-related disease (IgG4-RD) is a fascinating clinical entity proposed by Japanese investigators, and includes a wide variety of diseases, formerly diagnosed…”
Get full text

Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication by Kawahito, Yutaka, Morinobu, Akio, Kaneko, Yuko, Kohno, Masataka, Hirata, Shintaro, Kishimoto, Mitsumasa, Seto, Yohei, Sugihara, Takahiko, Tanaka, Eiichi, Ito, Hiromu, Kojima, Toshihisa, Matsushita, Isao, Nishida, Keiichiro, Mori, Masaaki, Murashima, Atsuko, Yamanaka, Hisashi, Nakayama, Takeo, Kojima, Masayo, Harigai, Masayoshi

“…The aim of this study was to update the Japan College of Rheumatology (JCR) clinical practice guidelines (CPG) for the management of rheumatoid arthritis (RA;…”
Get full text

Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis by Torii, Mie, Hashimoto, Motomu, Hanai, Akiko, Fujii, Takao, Furu, Moritoshi, Ito, Hiromu, Uozumi, Ryuji, Hamaguchi, Masahide, Terao, Chikashi, Yamamoto, Wataru, Uda, Miyabi, Nin, Kazuko, Morita, Satoshi, Arai, Hidenori, Mimori, Tsuneyo

“…Objectives: Sarcopenia is characterized by loss of muscle strength and mass, leading to falls and adverse health outcomes. Our aim was to determine the…”
Get full text

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details by Umehara, Hisanori, Okazaki, Kazuichi, Masaki, Yasufumi, Kawano, Mitsuhiro, Yamamoto, Motohisa, Saeki, Takako, Matsui, Shoko, Sumida, Takayuki, Mimori, Tsuneyo, Tanaka, Yoshiya, Tsubota, Kazuo, Yoshino, Tadashi, Kawa, Shigeyuki, Suzuki, Ritsuro, Takegami, Tsutomu, Tomosugi, Naohisa, Kurose, Nozomu, Ishigaki, Yasuhito, Azumi, Atsushi, Kojima, Masaru, Nakamura, Shigeo, Inoue, Dai

“…IgG4-related disease (IgG4RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by…”
Get full text

Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis by Kameda, Hideto, Fujii, Takao, Nakajima, Ayako, Koike, Ryuji, Sagawa, Akira, Kanbe, Katsuaki, Tomita, Tetsuya, Harigai, Masayoshi, Suzuki, Yasuo

“…Methotrexate (MTX), the anchor drug in the current treatment strategy for rheumatoid arthritis (RA), was first approved for treatment of RA in Japan in 1999 at…”
Get full text

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases by Tanaka, Yoshiya, Kuwana, Masataka, Fujii, Takao, Kameda, Hideto, Muro, Yoshinao, Fujio, Keishi, Itoh, Yasuhiko, Yasuoka, Hidekata, Fukaya, Shusaku, Ashihara, Konomi, Hirano, Daisuke, Ohmura, Koichiro, Tabuchi, Yuya, Hasegawa, Hisanori, Matsumiya, Ryo, Shirai, Yuichiro, Ogura, Takehisa, Tsuchida, Yumi, Ogawa-Momohara, Mariko, Narazaki, Hidehiko, Inoue, Yoshino, Miyagawa, Ippei, Nakano, Kazuhisa, Hirata, Shintaro, Mori, Masaaki

“…To update and revise the diagnostic criteria for mixed connective tissue disease (MCTD) issued by the Japan Research Committee of the Ministry of Health,…”
Get full text

Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalence estimates using a nationwide population-based questionnaire survey by Kojima, Masayo, Nakayama, Takeo, Tsutani, Kiichiro, Igarashi, Ataru, Kojima, Toshihisa, Suzuki, Sadao, Miyasaka, Nobuyuki, Yamanaka, Hisashi

“…Objectives: To elucidate the epidemiological characteristics of patients with rheumatoid arthritis (RA) in Japan using data from the Comprehensive Survey of…”
Get full text

Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials by Tanaka, Yoshiya, Tummala, Raj

“…Chronic activation of the type I interferon (IFN) pathway plays a critical role in systemic lupus erythematosus (SLE) pathogenesis. Anifrolumab is a human…”
Get full text

Current diagnosis and treatment of polymyositis and dermatomyositis by Sasaki, Hirokazu, Kohsaka, Hitoshi

“…Idiopathic inflammatory myopathies (IIMs) are heterogeneous disorders that affect the skeletal muscles. Polymyositis, dermatomyositis, and inclusion body…”
Get full text

Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: The Henan Rural Cohort Study by Dong, Xiaokang, Zhang, Honglei, Wang, Fang, Liu, Xiaotian, Yang, Kaili, Tu, Runqi, Wei, Min, Wang, Ling, Mao, Zhenxing, Zhang, Gongyuan, Wang, Chongjian

“…Objective: The aim of this study was to explore the latest prevalence of hyperuricemia and influencing factors in Chinese rural population. Methods: A survey…”
Get full text

Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data by Koto, Ruriko, Nakajima, Akihiro, Horiuchi, Hideki, Yamanaka, Hisashi

“…To assess gout and asymptomatic hyperuricemia in Japan and review treatment conditions. This retrospective cross-sectional study analyzed the prevalence of…”
Get full text

Association between cytokines and exosomes in synovial fluid of individuals with knee osteoarthritis by Gao, Kun, Zhu, Wenxiu, Li, Heng, Ma, Dujun, Liu, Weidong, Yu, Weiji, Wang, Lixin, Cao, Yafei, Jiang, Yong

“…Background: Cytokines in synovial fluid (SF) play a crucial role in knee osteoarthritis (KOA). Exosomes are nanovesicles that are abundant in SF and carry a…”
Get full text

Risk of malignancies in IgG4-related disease by Yamamoto, Motohisa, Takahashi, Hiroki, Tabeya, Tetsuya, Suzuki, Chisako, Naishiro, Yasuyoshi, Ishigami, Keisuke, Yajima, Hidetaka, Shimizu, Yui, Obara, Mikiko, Yamamoto, Hiroyuki, Himi, Tetsuo, Imai, Kohzoh, Shinomura, Yasuhisa

“…IgG4-related disease (IgG4-RD) is considered a systemic, chronic, and inflammatory disorder that is characterized by the enlargement of involved organs,…”
Get full text

Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials by Tanaka, Yoshiya, Kavanaugh, Arthur, Wicklund, Jason, McInnes, Iain B

“…In the treatment of rheumatoid arthritis (RA), Janus kinase inhibitors (jakinibs) represent an emerging class of targeted therapies in addition to biologics…”
Get full text

Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III study (OHZORA trial) by Tanaka, Yoshiya, Kawanishi, Masafumi, Nakanishi, Megumi, Yamasaki, Hironori, Takeuchi, Tsutomu

“…ABSTRACT Objective To assess the efficacy and safety through a 52-week treatment with subcutaneous ozoralizumab at 30 or 80 mg in patients with active…”
Get full text

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients by Fujiki, Youhei, Kotani, Takuya, Isoda, Kentaro, Ishida, Takaaki, Shoda, Takeshi, Yoshida, Shuzo, Takeuchi, Tohru, Makino, Shigeki

“…Objectives: We retrospectively investigated clinical prognostic factors for interstitial pneumonia (IP) in anti-melanoma differentiation-associated gene 5…”
Get full text